Showing results (191-200 of 262) with videos related to

Sort By:
Pageof 27
Rheumatology (Oxford, England)|February 8, 2005
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective studyP Durez, F Van den Bosch, L Corluy, et al.
Gastroenterologie Clinique Et Biologique|August 6, 2008
[Alcohol, steatohepatitis, insulin resistance and hepatitis C]P Couzigou, P Mathurin, L Serfaty, et al.
Journal Belge De Radiologie|November 1, 1990
Percutaneous transhepatic venous sampling of the pancreas in localizing insulinomasG Wilms, A L Baert, A N Dardenne, et al.
European Journal of Gastroenterology & Hepatology|November 1, 1996
Marked increase in serum CA 19-9 level in patients with alcoholic cirrhosis: report of four casesP Mathurin, J F Cadranel, D Bouraya, et al.
Journal of Viral Hepatitis|May 5, 2016
Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French caseS Deuffic-Burban, D Obach, V Canva, et al.
Calcified Tissue International|May 28, 2004
Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's diseaseG Beyens, E Van Hul, K Van Driessche, et al.
European Radiology|October 20, 1999
Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequencesS Precetti-Morel, M F Bellin, L Ghebontni, et al.
Gastroenterology|January 29, 1999
Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc GroupR Sobesky, P Mathurin, F Charlotte, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1981
Dissociation of parathyroid hormone bioactivity and immunoreactivity in pseudohypoparathyroidism type IC N de Deuxchaisnes, J A Fischer, M A Dambacher, et al.
Alimentary Pharmacology & Therapeutics|August 6, 1998
Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?P Mathurin, O Rixe, N Carbonell, et al.
Pageof 27